Gateway Advisory, LLC Precigen, Inc. Transaction History

Gateway Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$3.53 - $5.5 $71,200 - $110,935	-20,170 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$4.99 - $6.55 $100,648 - $132,113	20,170 New	20,170 $101,000
Q4 2020 Jan 11, 2021	SELL	$3.75 - $10.56 $63,750 - $179,520	-17,000 Closed	0 $0
Q3 2020 Oct 23, 2020	SELL	$3.5 - $6.2 $24,150 - $42,780	-6,900 Reduced 28.87%	17,000 $60,000
Q1 2020 Apr 07, 2020	BUY	$1.46 - $7.19 $34,894 - $171,841	23,900 New	23,900 $81,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $175M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Gateway Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Gateway Advisory, LLC with notifications on news.